News

Read the latest news about issues affecting the neuromuscular disease community.

Blog Post

FDA Approves argenx’s Vyvgart Hytrulo for Treatment of gMG

By Sujatha Gurunathan | June 20, 2023
Content wording on wooden cubes with speech bubbles.
Blog Post

In Case You Missed It…

By MDA Staff | June 8, 2023
Featured Article

Gene Therapy Options Grow With New Drug Approvals

By Larry Luxner | May 18, 2023
Two men in dark suit jackets and ties stand in front of a large blue screen with words projected on it: MDA Clinical & Scientific Conference.
Featured Article

2023 MDA Clinical & Scientific Conference Makes an Impact

By MDA Staff | May 18, 2023
Content wording on wooden cubes with speech bubbles.
Blog Post

In Case You Missed It…

By MDA Staff | May 8, 2023
FDA approved Biogen’s Qalsody for treatment of SOD1-ALS.
Blog Post

FDA Approves Biogen’s Qalsody for Treatment of SOD1-ALS

By Sujatha Gurunathan | April 25, 2023
Folder with paper text MEDICAID , on a table with a stethoscope and medical masks
Blog Post

Make Sure You Don’t Lose Your Medicaid Coverage

By Mark Fisher | March 13, 2023
A colorful peace mural painted on a street in Lviv, Ukraine.
Blog Post

For Ukrainians with Rare Diseases, Life is Still a Struggle

By Larry Luxner | March 8, 2023
Blog Post

2023 MDA Clinical & Scientific Conference: Abstract Library & Agenda

By Mindy Henderson | March 2, 2023
Blog Post

FDA Approves Reata’s SKYCLARYS for Treatment of FA

By Sujatha Gurunathan | February 28, 2023